Arrowhead Pharmaceuticals’ RNAi treatment has succeeded in a registrational test in patients with an ultra-rare lipid metabolism disorder, bolstering plans for a regulatory filing that …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
At IDWeek 2024 in Los Angeles, California, recent updates on mpox (formerly known as monkeypox) were discussed. Significant advancements and remaining hurdles in vaccination strategies
Funding from Innovate UK’s Transforming Medicines Manufacturing program supporting innovative technologies for intracellular drug delivery.
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Edwards Lifesciences has purchased a